How should levetiracetam (Keppra) dosage be adjusted during pregnancy for a woman currently taking the usual adult dose of 500–1500 mg twice daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levetiracetam Dosage in Pregnancy

Continue levetiracetam at the current dose (500-1500 mg twice daily) but implement proactive dose increases during pregnancy—particularly in the second and third trimesters—guided by therapeutic drug monitoring (TDM) to maintain preconception serum levels, as levetiracetam clearance increases substantially during pregnancy, potentially requiring dose escalations of up to 75%.

Pharmacokinetic Changes During Pregnancy

Levetiracetam undergoes significant pharmacokinetic alterations during pregnancy that directly impact seizure control:

  • Clearance increases progressively, with the most dramatic decline in concentration/dose ratios occurring in the first trimester, followed by continued decreases through the third trimester 1
  • Third trimester levels drop to approximately 47-62% of baseline postpartum concentrations under unchanged dosing 2
  • The mechanism is primarily increased renal clearance due to enhanced renal blood flow during pregnancy 3
  • Levetiracetam is FDA Pregnancy Category C, with animal studies showing developmental toxicity at doses similar to or greater than human therapeutic doses 4

Dosing Strategy

During Pregnancy

Baseline establishment: Obtain preconception levetiracetam levels if possible to establish an individualized target concentration 1, 5

Monitoring frequency: Check trough levels every 1-2 months throughout pregnancy, with particular attention during the third trimester 1, 3

Dose adjustments:

  • Expect to increase the total daily dose by approximately 75% during pregnancy compared to preconception 1
  • Adjust doses to maintain serum concentrations at or near preconception levels
  • For patients who were seizure-free for >12 months before pregnancy: maintain levels above 46% of preconception concentration 5
  • For patients with seizures within 12 months before pregnancy: maintain levels above 65% of preconception concentration, as this group shows significant correlation between low levels and seizure deterioration 5

Postpartum Period

Rapid dose reduction is essential as physiological changes reverse quickly after delivery:

Empiric tapering protocol (preferred approach based on recent evidence):

  • Day 1 postpartum: First dose reduction
  • Day 7 postpartum: Second dose reduction
  • Day 21 postpartum: Third dose reduction
  • Target return to preconception dose by 3 weeks postpartum 6

This empiric approach was not associated with increased seizure risk and was well-tolerated in 57 pregnancies, with no postpartum seizures in previously seizure-free patients 6.

Alternative approach: Continue TDM postpartum with dose adjustments based on levels, though this may be more cumbersome and was associated with slightly higher seizure rates in one study 6

Safety Considerations

Levetiracetam is considered relatively safe in pregnancy:

  • The FDA label notes it is Pregnancy Category C 4
  • In published case series of 147 patients, 2% experienced major congenital malformations and 4.8% had minor anomalies, though all occurred with antiepileptic drug polytherapy 3
  • No drug-drug interactions with other medications, including oral contraceptives 4
  • Umbilical cord/maternal plasma concentration ratio averages 1.21, indicating placental transfer 2

Folic acid supplementation: Prescribe 0.4-5 mg daily throughout pregnancy, as recommended for all women on antiepileptic drugs 3

Pregnancy registry enrollment: Strongly encourage enrollment in the UCB AED Pregnancy Registry (toll-free: 888-537-7734) or North American Antiepileptic Drug Pregnancy Registry (toll-free: 1-888-233-2334) 4

Common Pitfalls

Failure to increase doses proactively: Studies show that 40% of pregnant women on levetiracetam do not have their doses increased during pregnancy, despite known pharmacokinetic changes 7

Inadequate TDM utilization: Only 12.4% of pregnant women on levetiracetam receive therapeutic drug monitoring 7, which is essential for optimal management

Delayed postpartum dose reduction: Approximately 43% of women who had dose escalations during pregnancy do not have doses reduced postpartum 7, risking toxicity including CNS depression 4

Ignoring seizure history: The threshold for dose adjustment should be lower in women with recent seizures (<12 months before pregnancy), as they are at significantly higher risk for seizure deterioration with subtherapeutic levels 5

References

3
Research

Levetiracetam use in pregnancy.

The Annals of pharmacotherapy, 2009

Related Questions

How often should levetiracetam (Keppra) levels be checked?
What is the appropriate levetiracetam dosing regimen for adults?
What is the appropriate levetiracetam (Keppra) dose for a 2-year-old child weighing 11 kg?
What effect does levetiracetam have on respiration in typical adult patients?
What is the appropriate intravenous levetiracetam dosing (mg per kg) for children?
In patients with chronic liver disease, is a mechanical (metallic) valve or a bioprosthetic (tissue) valve preferred?
In patients with chronic liver disease and diabetes undergoing mitral valve replacement, is a mechanical valve or a bioprosthetic valve preferred?
In a patient with a one‑year history of dyspnea, orthopnea requiring two pillows, waking from sleep with air hunger (paroxysmal nocturnal dyspnea), a clear chest radiograph, denial of snoring or witnessed apneas, and decreased breath sounds on the right side, what is the most likely diagnosis?
In a patient with hepatic cirrhosis, hypoglycemia and hypotension who is receiving propranolol and spironolactone, what is the appropriate maximum dose to which furosemide can be titrated?
For a 55‑year‑old patient with compensated chronic liver disease (normal liver‑function tests) and diabetes mellitus with hemoglobin A1c 8 %, which mitral valve prosthesis (mechanical versus bioprosthetic) is preferred?
What medication is recommended for treating constipation during pregnancy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question